Suivez-nous
FR
FR
FR

L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕
22 novembre 2018, 08:57
385
Minsk signed the Paris Declaration on accelerating measures to end the AIDS epidemic

Minsk signed the Paris Declaration on accelerating measures to end the AIDS epidemic

On the third day of the II Regional Meeting on expanding access to high-quality and affordable drugs and diagnostic products for treating and preventing HIV in the EECA countries, Minsk supported the Paris Declaration on Accelerating Action to End the AIDS Epidemic in Large ...
19 octobre 2018, 10:47
511
Gilead and Aelix join forces to develop a promising anti-HIV combination

Gilead and Aelix join forces to develop a promising anti-HIV combination

American pharmaceutical company Gilead Sciences - the world leader in the development of drugs for the treatment of HIV and hepatitis C - has teamed up with the Spanish Aelix Therapeutics in order to develop a fundamentally new ART-regimen, according to PMLive.
18 octobre 2018, 13:38
439
IDWeek-2018 presented new data confirming the long-term effectiveness of ART-schemes “in one pill”

IDWeek-2018 presented new data confirming the long-term effectiveness of ART-schemes “in one pill”

According to a number of studies presented at the IDWeek-2018 conference in San Francisco, several newest ART-schemes “in one pill” are capable of supporting an undetectable burden of HIV for two years or more.
17 octobre 2018, 13:20
407
Spanish scientists told about promising results of HIV suppression in stem cell transplantation

Spanish scientists told about promising results of HIV suppression in stem cell transplantation

A group of researchers from the Madrid Hospital. Gregorio Maranyon and the IrsiCaixa HIV Research Institute of Barcelona last Tuesday reported on the impressive results of suppressing HIV-positive patients with virus strains in hidden reservoirs thanks to the stem cell transplant ...
15 octobre 2018, 12:20
391
American patients admitted that they are not ready to switch to new ways of ART delivery

American patients admitted that they are not ready to switch to new ways of ART delivery

According to a US study published in Open Forum Infectious Diseases, two-thirds of people taking combined antiretroviral therapy (ART) will be interested in switching to the oral regimen once a week. The idea of switching to long-term injection therapy is supported by less ...
26 septembre 2018, 14:08
778
Immunotherapy of HIV passed the first phase of clinical trials

Immunotherapy of HIV passed the first phase of clinical trials

Preliminary results from phase I clinical trials demonstrated the safety and tolerability of cell therapy, including the introduction of artificially expanded T-cells with widely neutralizing antibodies (#bNAbs) into the blood of HIV-positive volunteers who had previously ...
25 septembre 2018, 14:04
777
American patients with hepatitis C will be available branded generics Gilead

American patients with hepatitis C will be available branded generics Gilead

On Monday, September 24, the American biopharmaceutical company Gilead Sciences Inc. said that it expects to launch in the US the production of a number of analogues for its own products. Among the applicants for the release are generic drugs for the treatment of hepatitis ...
24 septembre 2018, 13:52
702
The number of heterosexuals with HIV in Australia is growing - experts

The number of heterosexuals with HIV in Australia is growing - experts

According to the latest statistics published today by the Kirby Institute (University of New South Wales, Australia), the number of diagnoses of "#HIV infection" among Australian heterosexual men over the past five years has increased by 10%. The study showed that more than ...
18 septembre 2018, 13:49
638
Scientists: HIV should be considered a major risk factor for cardiovascular disease

Scientists: HIV should be considered a major risk factor for cardiovascular disease

People living with HIV are twice as likely to suffer from cardiovascular disease (#CVD), the results of a meta-analysis published in Circulation magazine show. According to researchers, over the past 20 years, the number of CVDs associated with HIV has tripled. Today this ...
17 septembre 2018, 13:42
567
EMA will consider an application for the registration of an antiviral drug dolutegravir / lamivudine

EMA will consider an application for the registration of an antiviral drug dolutegravir / lamivudine

September 14 became known that the pharmaceutical company ViiV Healthcare, part of the GlaxoSmithKline structure, applied to the European Medicines Agency (#EMA) for the registration of a two-component antiretroviral dolutegravir / lamivudine intended for the treatment of ...